Gurlek, Feridun, and Eyyüp Tasdemir. 2020. “Is It an Advantage or Disadvantage to Usage Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in COVID-19 Patients?”. International Journal of Research in Medical Sciences 8 (12):4200-4205. https://doi.org/10.18203/2320-6012.ijrms20205289.